홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
NRIX
#2094
Nurix Therapeutics, Inc. Common stock
16.970
0
USD
+4.11%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+4.11%
월간 변동
+10.63%
6달 변화
+51.38%
년간 변동율
+51.38%
이전 종가
16.300
0
Open
16.630
0
Bid
Ask
Low
16.510
0
High
17.025
0
양
1 230
마켓
주식
헬스케어
NRIX
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
75.89 M
103.41 M
76.45 M
76.88 M
102.84 M
—
Valuation ratios
Enterprise value
1.52 B
1.56 B
843.84 M
621.97 M
1.49 B
4.52 B
Price to earnings ratio
-7.46
-4.99
-4.67
-3.08
-5.54
-18.28
Price to sales ratio
26.44
18.99
10.87
8.78
17.45
56.09
Price to cash flow ratio
-8.36
-10.11
-4.35
-3.15
-5.87
-23.48
Price to book ratio
2.74
0.78
0.5
0.39
2.72
4.39
EBITDA 비율에 대한 기업 가치
-6.78
-4.83
-3.46
-2.23
-5.04
-15.55
Profitability ratios
Return on assets %
-0.09
0.14
-0.07
-0.17
-0.11
-0.22
Return on equity %
-0.11
0.18
-0.1
-0.23
-0.15
-0.29
Return on invested capital %
-215.25
278.18
-163.66
-274.54
-248.16
-408.18
Gross margin %
100
100
100
100
100
400
Operating margin %
-486.73
1 479.45
-109.68
-1 157.65
-612.03
-399.92
EBITDA margin %
-513.02
-1 511.08
-115.81
-1 185.48
-625.78
-3 438.16
Net margin %
-440.75
1 394.34
-98.66
-1 094.77
-576.13
-375.22
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
6.46
6.01
6.82
5.35
7.02
25.2
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.02
0.01
0.07
0.01
0.02
0.12
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.73
0.65
-0.75
-0.68
-0.78
-1.56
EBIT per share
-0.96
-0.84
-0.58
-1.09
-0.96
-3.46
EBITDA per share
-1.02
-0.86
-0.61
-1.11
-0.98
-3.56
Total debt per share
—
—
—
—
—
—
Cash per share
9.08
4.91
5.79
5.1
6.84
22.64
Net current asset value per share
9.23
5.04
6.14
5.24
7
23.42
Tangible book value per share
7.85
4.37
5.34
4.42
6.22
20.34
Working capital per share
7.8
4.2
5.24
4.26
6
19.7
Book value per share
7.85
4.37
5.34
4.42
6.22
20.34
뉴스
Does Nurix Therapeutics (NRIX) Have the Potential to Rally 85.84% as Wall Street Analysts Expect?
Company News for Apr 9, 2026
Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Lags Revenue Estimates
Nurix Therapeutics (NRIX) Moves 6.9% Higher: Will This Strength Last?
Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates
Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Misses Revenue Estimates
Nurix Therapeutics amends equity distribution agreement for $413.65 million stock offering
캐시 우드의 ARK, 로쿠 매도, 알리바바와 바이오엔테크 매수
Nurix (NRIX) 법률 책임자, 125,792달러 상당 주식 매도
Ring, chief legal officer, sells Nurix (NRIX) shares for $125,792
Nurix Therapeutics Stock Sees RS Rating Jump To 82
Nurix 법률 책임자, NRIX 주식 23만 7천 달러 매도